Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation.

Ganoderma lucidum

OncologyImmune supportCognition & nervesMetabolic health

SpeciesReishi, Lingzhi

JournalFrontiers in pharmacology

Year2025

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Ganoderma lucidum in Frontiers in pharmacology in 2025. MycoData maps the paper to oncology, immune support, cognition & nerves, metabolic health based on its title, species context, article metadata, and study classification.

Citation

Li W, Huang W, Zhou P, Yao Y, Cai B, Ye S (2025). Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation. Frontiers in pharmacology https://doi.org/10.3389/fphar.2025.1690192 PMID: 41378217

Open citation